Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-02-24 @ 11:36 AM
Study NCT ID:
NCT02657005
Status:
TERMINATED
Last Update Posted:
2025-02-12
First Post:
2016-01-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
Sponsor:
Oncternal Therapeutics, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TK216-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None